News
Shares in Hims Hers Health Inc (NYSE:HIMS) soared over 40% on Tuesday after the telehealth group announced a "long-term collaboration" with Novo Nordisk A/S (NYSE:NVO) to offer the Danish firm’s ...
Peter Loftus is a reporter for The Wall Street Journal in Philadelphia covering the pharmaceutical and medical-device ...
At-home testing is growing and packaging plays a big role in helping customers use them correctly to ensure accurate results.
8d
MarketBeat on MSNEli Lilly Nails Oral GLP-1 Trial-Here's What It Means for LLYCompanyOverview|NYSE:LLY] The world’s largest pharmaceutical stock, Eli Lilly and Company (NYSE: LLY), is back in the green ...
Pharmaceutical giant Eli Lilly alleges the companies are selling illegal off-brand versions of its best-selling diabetes and ...
(CNN) — Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 diabetes lose an average of nearly 8% of their body weight after ...
Eli Lilly said its experimental pill met its goals in a pivotal study, helping diabetes patients lower blood sugar—and even reduce weight, bringing an oral version of the booming class of drugs ...
Cemag Care, a pharmaceutical company focusing on the development of innovative solutions to address unmet medical needs, is pleased to announce its partnership with Clara Care Inc. as the exclusive U.
Eli Lilly plans to present the ACHIEVE-1 results at the upcoming 85th Scientific Sessions of the American Diabetes Association and publish them in a peer-reviewed journal. Further data from the ...
Eli Lilly's shares were rallying ahead of the opening bell after the drug company's first GLP-1 pill for diabetes and weight loss took a step closer to hitting the market. In premarket trading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results